192 related articles for article (PubMed ID: 34131888)
1. Serum fatty acid binding protein 5 (FABP5) as a potential biomarker of inflammation in psoriasis.
Kozłowska D; Myśliwiec H; Harasim-Symbor E; Milewska AJ; Chabowski A; Flisiak I
Mol Biol Rep; 2021 May; 48(5):4421-4429. PubMed ID: 34131888
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Galectin3 levels in psoriatic patients treated by narrow-band UVB phototherapy.
Khater MH; AbdallaAlhabib S; Elkshishy KA; Khattab FM
J Dermatolog Treat; 2020 Dec; 31(8):758-762. PubMed ID: 31557066
[No Abstract] [Full Text] [Related]
3. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
[TBL] [Abstract][Full Text] [Related]
4. Epidermal barrier and oxidative stress parameters improve during in 311 nm narrow band UVB phototherapy of plaque type psoriasis.
Darlenski R; Hristakieva E; Aydin U; Gancheva D; Gancheva T; Zheleva A; Gadjeva V; Fluhr JW
J Dermatol Sci; 2018 Jul; 91(1):28-34. PubMed ID: 29610017
[TBL] [Abstract][Full Text] [Related]
5. Decreased Systemic Levels of Endocan-1 and CXCL16 in Psoriasis Are Restored following Narrowband UVB Treatment.
Sigurdardottir G; Ekman AK; Verma D; Enerbäck C
Dermatology; 2018; 234(5-6):173-179. PubMed ID: 30176661
[TBL] [Abstract][Full Text] [Related]
6. Effect of narrowband ultraviolet B therapy on inflammatory markers and body fat composition in moderate to severe psoriasis.
Romaní J; Caixàs A; Carrascosa JM; Ribera M; Rigla M; Luelmo J
Br J Dermatol; 2012 Jun; 166(6):1237-44. PubMed ID: 22309899
[TBL] [Abstract][Full Text] [Related]
7. TWEAK levels in psoriatic patients treated with narrowband ultraviolet B and methotrexate.
Hegazy EM; El Taieb MA; Ibrahim HM; Rageh EM; Ahmed NM; Ibrahim AK; Younis AM; Ali MA
J Cosmet Dermatol; 2024 May; 23(5):1905-1911. PubMed ID: 38299446
[TBL] [Abstract][Full Text] [Related]
8. Liver fatty acid-binding protein might be a predictive marker of clinical response to systemic treatment in psoriasis.
Baran A; Kiluk P; Maciaszek M; Świderska M; Flisiak I
Arch Dermatol Res; 2019 Jul; 311(5):389-397. PubMed ID: 30993401
[TBL] [Abstract][Full Text] [Related]
9. Serum fatty acid profile in psoriasis and its comorbidity.
Myśliwiec H; Baran A; Harasim-Symbor E; Myśliwiec P; Milewska AJ; Chabowski A; Flisiak I
Arch Dermatol Res; 2017 Jul; 309(5):371-380. PubMed ID: 28585093
[TBL] [Abstract][Full Text] [Related]
10. A randomized, 'head-to-head' pilot study comparing the effects of etanercept monotherapy vs. etanercept and narrowband ultraviolet B (NB-UVB) phototherapy in obese psoriasis patients.
Park KK; Wu JJ; Koo J
J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):899-906. PubMed ID: 22702846
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of lipocalin-2 and retinol-binding protein-4 are increased in psoriatic patients and correlated with baseline PASI.
Romaní J; Caixàs A; Ceperuelo-Mallafré V; Carrascosa JM; Ribera M; Rigla M; Vendrell J; Luelmo J
Arch Dermatol Res; 2013 Mar; 305(2):105-12. PubMed ID: 23242471
[TBL] [Abstract][Full Text] [Related]
12. Serum Fatty Acid-Binding Protein 4 is Increased in Patients with Psoriasis.
Baran A; Świderska M; Bacharewicz-Szczerbicka J; Myśliwiec H; Flisiak I
Lipids; 2017 Jan; 52(1):51-60. PubMed ID: 27864793
[TBL] [Abstract][Full Text] [Related]
13. Narrowband UVB treatment increases serum 25-hydroxyvitamin D levels in patients with chronic plaque psoriasis.
Saleky S; Bulur I; Saraçoğlu ZN
Cutis; 2017 Jun; 99(6):431-435. PubMed ID: 28686753
[TBL] [Abstract][Full Text] [Related]
14. Influence of narrowband ultraviolet B phototherapy on serum tumour necrosis factor-like weak inducer of apoptosis (TWEAK) in patients with psoriasis.
Myśliwiec H; Kiluk P; Myśliwiec P; Żelazowska-Rutkowska B; Baran A; Flisiak I
Clin Exp Dermatol; 2017 Oct; 42(7):786-790. PubMed ID: 28748592
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of tumor necrosis factor-alpha in patients with psoriasis before, during and after narrow-band UVB phototherapy.
Rossi MT; Venturini M; Zanca A; Arisi M; Fusano M; Sottini A; Serana F; Imberti L; Calzavara-Pinton P
G Ital Dermatol Venereol; 2018 Feb; 153(1):1-4. PubMed ID: 28704992
[TBL] [Abstract][Full Text] [Related]
16. Tumour necrosis factor alpha (TNF-alpha)-converting enzyme (TACE) and soluble TNF-alpha receptor type 1 in psoriasis patients treated with narrowband ultraviolet B.
Serwin AB; Sokolowska M; Chodynicka B
Photodermatol Photoimmunol Photomed; 2007 Aug; 23(4):130-4. PubMed ID: 17598866
[TBL] [Abstract][Full Text] [Related]
17. Adipocyte Fatty Acid-Binding Protein as a Novel Marker of Psoriasis and Clinical Response to Acitretin.
Baran A; Kiluk P; Świderska M; Maciaszek M; Myśliwiec H; Flisiak I
Lipids; 2019 Aug; 54(8):445-452. PubMed ID: 31281982
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein serum level in patients with psoriasis before and after treatment with narrow-band ultraviolet B.
Farshchian M; Ansar A; Sobhan M; Hoseinpoor V
An Bras Dermatol; 2016; 91(5):580-583. PubMed ID: 27828628
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome affects narrow-band UVB phototherapy response in patients with psoriasis.
Rui W; Xiangyu D; Fang X; Long G; Yi Y; Wenjuan W; Tian H; Xiaoning Z; Yong Z; Jianfeng F; Hengjin L; Chengxin L
Medicine (Baltimore); 2017 Dec; 96(50):e8677. PubMed ID: 29390261
[TBL] [Abstract][Full Text] [Related]
20. Reduction in tissue plasmin: a new mechanism of action of narrowband ultraviolet B in psoriasis.
Metwally D; Sayed K; Abdel Hay R; Rashed L
Clin Exp Dermatol; 2015 Jun; 40(4):416-20. PubMed ID: 25557337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
